Tags

Type your tag names separated by a space and hit enter

Increased plasma visfatin concentrations in women with polycystic ovary syndrome.
Fertil Steril. 2007 Aug; 88(2):401-5.FS

Abstract

OBJECTIVE

To test the hypothesis that plasma visfatin concentrations will be higher in women with polycystic ovary syndrome (PCOS) than in women without PCOS.

DESIGN

Clinical study.

SETTING

University hospital.

PATIENT(S)

A total of 52 women were evaluated. Twenty-six had PCOS, and the remaining 26 were healthy women with regular menstrual cycles who served as control subjects.

INTERVENTION(S)

Plasma visfatin concentrations were analyzed with the use of RIA.

MAIN OUTCOME MEASURE(S)

Serum concentrations of FSH, LH, TSH, PRL, T, insulin, E(2), and visfatin.

RESULT(S)

Plasma visfatin concentrations were significantly higher in the PCOS group (336.8 +/- 50.2 ng/mL) than in the healthy control group (282.4 +/- 43.3 ng/mL). Logistic regression analysis indicated a significant association between odds ratio (OR) values of PCOS and visfatin levels (OR = 2.81; 95% confidence interval [CI], 2.74-2.90), T (OR = 3.39; 95% CI, 2.85-4.16), and LH levels (OR = 3.49; 95% CI, 2.79-4.56). There was no correlation between plasma visfatin concentrations and T, insulin, and LH levels or age in either the PCOS group or the control group. We observed that plasma visfatin levels were positively correlated with body mass index in the PCOS group (r = 0.396, r(2) = 0.157) but not in the control group (r = -0.328, r(2) = 0.108).

CONCLUSION(S)

Our data show that women with PCOS exhibit higher plasma visfatin levels than control subjects of similar body mass index. Further studies are required to clarify the etiology and effects of hypervisfatinemia in women with PCOS.

Authors+Show Affiliations

Department of Obstetrics and Gynecology, Graduate Institute of Medicine, College of Medicine, Kaohsiung, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

17335820

Citation

Chan, Te-Fu, et al. "Increased Plasma Visfatin Concentrations in Women With Polycystic Ovary Syndrome." Fertility and Sterility, vol. 88, no. 2, 2007, pp. 401-5.
Chan TF, Chen YL, Chen HH, et al. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril. 2007;88(2):401-5.
Chan, T. F., Chen, Y. L., Chen, H. H., Lee, C. H., Jong, S. B., & Tsai, E. M. (2007). Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertility and Sterility, 88(2), 401-5.
Chan TF, et al. Increased Plasma Visfatin Concentrations in Women With Polycystic Ovary Syndrome. Fertil Steril. 2007;88(2):401-5. PubMed PMID: 17335820.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Increased plasma visfatin concentrations in women with polycystic ovary syndrome. AU - Chan,Te-Fu, AU - Chen,Yi-Ling, AU - Chen,Hung-Hseng, AU - Lee,Chien-Hung, AU - Jong,Shiang-Bin, AU - Tsai,Eing-Mei, Y1 - 2007/02/28/ PY - 2006/05/25/received PY - 2006/11/15/revised PY - 2006/11/27/accepted PY - 2007/3/6/pubmed PY - 2007/9/8/medline PY - 2007/3/6/entrez SP - 401 EP - 5 JF - Fertility and sterility JO - Fertil Steril VL - 88 IS - 2 N2 - OBJECTIVE: To test the hypothesis that plasma visfatin concentrations will be higher in women with polycystic ovary syndrome (PCOS) than in women without PCOS. DESIGN: Clinical study. SETTING: University hospital. PATIENT(S): A total of 52 women were evaluated. Twenty-six had PCOS, and the remaining 26 were healthy women with regular menstrual cycles who served as control subjects. INTERVENTION(S): Plasma visfatin concentrations were analyzed with the use of RIA. MAIN OUTCOME MEASURE(S): Serum concentrations of FSH, LH, TSH, PRL, T, insulin, E(2), and visfatin. RESULT(S): Plasma visfatin concentrations were significantly higher in the PCOS group (336.8 +/- 50.2 ng/mL) than in the healthy control group (282.4 +/- 43.3 ng/mL). Logistic regression analysis indicated a significant association between odds ratio (OR) values of PCOS and visfatin levels (OR = 2.81; 95% confidence interval [CI], 2.74-2.90), T (OR = 3.39; 95% CI, 2.85-4.16), and LH levels (OR = 3.49; 95% CI, 2.79-4.56). There was no correlation between plasma visfatin concentrations and T, insulin, and LH levels or age in either the PCOS group or the control group. We observed that plasma visfatin levels were positively correlated with body mass index in the PCOS group (r = 0.396, r(2) = 0.157) but not in the control group (r = -0.328, r(2) = 0.108). CONCLUSION(S): Our data show that women with PCOS exhibit higher plasma visfatin levels than control subjects of similar body mass index. Further studies are required to clarify the etiology and effects of hypervisfatinemia in women with PCOS. SN - 1556-5653 UR - https://www.unboundmedicine.com/medline/citation/17335820/Increased_plasma_visfatin_concentrations_in_women_with_polycystic_ovary_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0015-0282(06)04662-0 DB - PRIME DP - Unbound Medicine ER -